Blue Cross in-house product development capabilities deliver products of world class quality at affordable price to consumer by focusing on Quality by Design (QbD) through various Design of experiments (DoE). The inbuilt quality of products is assured through scientific way of product development at R&D scale, stability studies, transfer of technology from lab scale to mass production, process validation, analytical method development and Analytical Method validation.
Blue Cross R&D facility is recognized by Department for Scientific & Industrial Research (DSIR), Government of India.
幸运赛车Blue Cross's R&D division constantly strives towards development of new formulations, New Drug Delivery Systems and continual innovation and improvement in existing products。 The therapeutic segments like Antibacterial, Pain management, Antispasmodics, Cough & Cold Preparations, Antihypertensive, Antidiabetics, Anti-Ulcerate, Dermatological etc。 are focus categories where products are developed in various dosage forms。
Formulation research is a major thrust area in the development of technology based generic formulations comprising Solid Orals [Dispersible Tablets, Orally Disintegrating Tablets, Immediate Release, sustained Released, Controlled Released, Extended Release and Delayed Release], Liquid orals, Topical preparations etc。